Patrick Austin1, Lynn Gerber2,3, James M Paik2, Jillian K Price2, Carey Escheik2,3, Zobair M Younossi2,3. 1. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA - Patrick.Austin@inova.org. 2. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA. 3. Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA.
Abstract
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver disease worldwide. Exercise has proven effective in treating NAFLD, and many clinical initiatives seek to increase uptake of exercise in this population. This study aimed to elucidate the physiological responses of individuals with NAFLD to graded exercise testing. METHODS: Seventeen participants with presumed NAFLD and 15 without were assessed through symptom-limited, Modified Bruce treadmill testing. Gas exchange, impedance cardiometry, and perceived exertion ratings were used to assess exercise performance, response and perception. Patient-self reports were also obtained. RESULTS: Individuals with NAFLD were older (49.00 [38.50, 54.50] vs. 30.00[22.00, 42.00] years, P=0.018) with higher Body Mass Index (32.54[27.38, 34.98] vs. 25.62[23.76, 30.72], P=0.012), but demonstrated no other differences with regards to sex, race, blood pressure, resting heart rate, or habitual activity. Individuals demonstrated no between-group differences in total exercise time, anaerobic threshold (AT) onset time, or cardiac output. While individuals with NAFLD displayed a decreased peak oxygen consumption (VO2) (25.70[23.60, 27.20] vs. 31.00[26.00, 42.70], P=0.036) relative to controls, a similar difference was not found for the percentage of predicted VO2max achieved, suggesting that NAFLD may not impair exercise physiology beyond what is observed in obese individuals. CONCLUSIONS: Exercise capacity appears preserved in participants with NAFLD relative to their control counterparts. Peak VO2 is reduced among these patients, suggesting impaired aerobic capacity. Future studies may seek to determine whether this finding is directly related to the diagnosis of NAFLD, or more generally to states of obesity and physical deconditioning.
BACKGROUND:Nonalcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver disease worldwide. Exercise has proven effective in treating NAFLD, and many clinical initiatives seek to increase uptake of exercise in this population. This study aimed to elucidate the physiological responses of individuals with NAFLD to graded exercise testing. METHODS: Seventeen participants with presumed NAFLD and 15 without were assessed through symptom-limited, Modified Bruce treadmill testing. Gas exchange, impedance cardiometry, and perceived exertion ratings were used to assess exercise performance, response and perception. Patient-self reports were also obtained. RESULTS: Individuals with NAFLD were older (49.00 [38.50, 54.50] vs. 30.00[22.00, 42.00] years, P=0.018) with higher Body Mass Index (32.54[27.38, 34.98] vs. 25.62[23.76, 30.72], P=0.012), but demonstrated no other differences with regards to sex, race, blood pressure, resting heart rate, or habitual activity. Individuals demonstrated no between-group differences in total exercise time, anaerobic threshold (AT) onset time, or cardiac output. While individuals with NAFLD displayed a decreased peak oxygen consumption (VO2) (25.70[23.60, 27.20] vs. 31.00[26.00, 42.70], P=0.036) relative to controls, a similar difference was not found for the percentage of predicted VO2max achieved, suggesting that NAFLD may not impair exercise physiology beyond what is observed in obese individuals. CONCLUSIONS: Exercise capacity appears preserved in participants with NAFLD relative to their control counterparts. Peak VO2 is reduced among these patients, suggesting impaired aerobic capacity. Future studies may seek to determine whether this finding is directly related to the diagnosis of NAFLD, or more generally to states of obesity and physical deconditioning.
Authors: Jonathan G Stine; Ian R Schreibman; Alison J Faust; Jessica Dahmus; Benjamin Stern; Christopher Soriano; Gloriany Rivas; Breianna Hummer; Scot R Kimball; Nate R Geyer; Vernon M Chinchilli; Rohit Loomba; Kathryn Schmitz; Christopher Sciamanna Journal: Hepatology Date: 2022-01-22 Impact factor: 17.298
Authors: Marcella Burghard; Tim Takken; Merel M Nap-van der Vlist; Sanne L Nijhof; C Kors van der Ent; Harry G M Heijerman; H J Erik Hulzebos Journal: Ther Adv Respir Dis Date: 2022 Jan-Dec Impact factor: 4.031
Authors: Simon Hohenester; Veronika Kanitz; Tobias Schiergens; Claudia Einer; Jutta Nagel; Ralf Wimmer; Florian P Reiter; Alexander L Gerbes; Enrico N De Toni; Christian Bauer; Lesca Holdt; Doris Mayr; Christian Rust; Max Schnurr; Hans Zischka; Andreas Geier; Gerald Denk Journal: Int J Mol Sci Date: 2020-11-14 Impact factor: 5.923